| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |